A phase 2A trial recently received confirmation to proceed in investigating psilocybin-assisted psychotherapy in the treatment of adult patients with IBS.
Jim Gilligan, PhD, MBIS
Advertisement
Dr Gilligan is the chief science officer and interim CEO of Tryp Therapeutics.
Articles by Jim Gilligan, PhD, MBIS
This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Evidence-Based Psychotherapy and Psychopharmacology for Mood Disorders: A Conversation With Holly A. Swartz, MD
2
Can the Initial Antipsychotic Influence Years of Weight Gain?
3
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms
4
How to Approach Conversations With Adult Patients Who Might Have ADHD: New Tools and Insights
5
